Highlights
A collection of news and information related to Avandia (drug) published by this site and its partners.
Displaying items 1-12 of 21
» View latimes.com items only
1
2
Next >
-
Girardi | Keese
Given its deep bench of skilled trial attorneys—who include partner Amy Fisch Solomon —Girardi | Keese has pioneered litigation in the personal injury field, achieving more than $10 billion for its injured clients. “Amy is truly one of...
Tags: Laws, Vioxx (drug), Yaz (drug), Yasmin (drug), Crime, Law and Justice
-
GlaxoSmithKline to pay $3 billion healthcare fraud settlement, U.S. says
Pharmaceutical drug maker GlaxoSmithKline will pay $3 billion and plead guilty to federal charges to resolve a slew of criminal and civil issues stemming from its use of kickbacks, mis-branding and other misconduct to market drugs such as Paxil,...
Tags: Corporate Crime, Trials, Companies and Corporations, Sexual Dysfunction, Bribery
-
Sulfonylureas for diabetes increase risk of heart disease and death, study finds
Booster ShotsSulfonylureas, the first family of oral drugs used for treating type 2 diabetes, increase the risk of death from all causes by as much as 61% compared with the newer drug metformin, British researchers have found. Some researchers have suspected...... -
Diabetics' risk of heart attack
Special to The TimesSome 15 million Americans have been diagnosed with Type 2 diabetes mellitus. About 85% take some form of medication or insulin to control it. Recently, scientists reported that one such drug, called Avandia, increased a diabetic's risk of heart attacks by...Tags: Boston, Death, Tallahassee (Leon, Florida), Obesity, Medical Research
-
State AG sues maker of diabetes drugs for false advertising
Maryland Attorney General Douglas F. Gansler said Wednesday he has filed a lawsuit against GlaxoSmithKline, LLC for falsely saying three of its diabetes drugs were better than others on the market. The company also withheld data that showed the drugs...
Tags: GlaxoSmithKline PLC, Litigation, Trials, Crime, Law and Justice, Diabetes
-
What drugs are going generic this year and next
Dozens of brand-name prescription drugs are losing their patent protection, allowing generic versions to enter the market and consumers to save 30 to 80 percent on those medications, said David Belian, director of media relations for the Generic...
Tags: COPD, Cymbalta (drug), Osteoporosis, Viral Diseases and Infections, Actos (drug)
-
Pennsylvania to receive more than $13 million as part of GlaxoSmithKline healthcare fraud settlement
Assistant Press SecretaryAttorney General Linda Kelly today announced that Pennsylvania will receive more than $13 million as part of the largest healthcare fraud settlement in United States history. Kelly said that GlaxoSmithKline, a British based pharmaceutical company that...Tags: Valtrex (drug), Sexual Dysfunction, Health Insurance, Behavioral Conditions, Medicaid
-
|Story
Tags: GlaxoSmithKline PLC, Politics, U.S. Department of Justice, Trials, Crime, Law and Justice
-
Avandia Hearings Expose FDA Rifts
AP Business WriterThe diabetes pill Avandia has been used by millions of patients and racked up billions in sales in more than a decade on the market. This week the Food and Drug Administration is trying to answer a seemingly simple question: Does it cause heart attacks?...Tags: GlaxoSmithKline PLC, Trials, Science, Crime, Law and Justice, Actos (drug)
-
|Story
Tags: Margaret Hamburg, GlaxoSmithKline PLC, Politics, Economic Sanctions, Foreign Aid
-
FDA panel says heart risks with diabetes drug Avandia significantly higher than other meds
Staff WriterWASHINGTON (AP) — Federal health experts say the much-debated diabetes pill Avandia increases the risk of heart attack compared to other diabetes drugs. A majority of 33 expert panelists said the former blockbuster drug is riskier than older...Tags: GlaxoSmithKline PLC, Drugs and Medicines, Health, Heart and Circulatory System, Diabetes
Mar 25, 2013
|Story| Los Angeles Times
Jul 2, 2012
|Story| Los Angeles Times
Dec 4, 2009
| Los Angeles Times
Jun 4, 2007
|Story| Los Angeles Times
Feb 20, 2013
|Story| Baltimore Sun
Aug 1, 2012
|Story| Chicago Tribune
Jul 2, 2012
|Story| WPMT-LTV
Feb 7, 2011
|Story| Reuters
Jul 13, 2010
|Story| Associated Press
Sep 24, 2010
|Resource Link| Health Portal
Sep 23, 2010
|Story| Hola Hoy
Jul 14, 2010
|Story| Associated Press


